Skip to main content
Glama
seelpeed-debug

export-controls-agent

Review EAR Part 744 end-use and end-user issues

check_part744_enduse

List EAR Part 744 end-use/end-user red flags (military, nuclear, missile, chem/bio, US-person, advanced-node). Does not screen restricted parties or clear transactions.

Instructions

List the EAR Part 744 end-use and end-user issues that must be reviewed for a transaction: military end use (744.21) including the 50 percent affiliates rule, military-intelligence (744.22), nuclear (744.2), missile (744.3), chemical/biological (744.4), U.S.-person activities (744.6), and the supercomputer / advanced-node IC / semiconductor-manufacturing-equipment controls (744.23). This tool performs NO restricted-party screening and cannot clear a transaction; an empty issue list means the heuristic found nothing, not that the transaction is permissible.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
eccnNoECCN with subparagraph if known, e.g. 3B001.f.1, 3A090.c, or EAR99.
flagsNo
endUseNoStated end-use.
endUserNoEnd-user name or description.
endUserScreeningNo
additionalPartiesNoOther named parties to screen: ultimate consignee, intermediate consignees, purchaser, freight forwarders, banks.
destinationCountryYesDestination country. Matched against 15 C.F.R. Part 740, Supplement No. 1.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observedv0.4.1

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full burden, and it does so clearly: it discloses that the tool is a heuristic, performs NO restricted-party screening, cannot clear a transaction, and that an empty issue list does not mean the transaction is permissible. These are exactly the behavioral limitations an agent needs to avoid over-reliance.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences with no filler: the first front-loads the purpose and scope in a compact enumerated list, and the second delivers the critical caveats. Every clause earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex nested-schema tool with no output schema or annotations, the description explains what it returns ('list of issues'), what an empty result means, and what it cannot do. It could add a bit more detail on the exact output format or how flags should be populated, but the essential invocation and interpretation guidance is present.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 71%, so the schema already explains many parameters. The description adds regulatory meaning beyond individual field labels by mapping the issue categories to Part 744 sections and mentioning the 50 percent affiliates rule, which clarifies the role of ownership and end-use flags. It does not walk through every parameter, but the aggregate framing plus the 'no screening' caveat provides useful selection context.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a specific verb and resource: 'List the EAR Part 744 end-use and end-user issues that must be reviewed,' and then enumerates the exact regulatory sections covered (744.21, 744.22, 744.2, 744.3, 744.4, 744.6, 744.23). It also distinguishes itself from restricted-party screening and license-clearance tools by stating what it does not do.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The first sentence identifies the use case (reviewing Part 744 end-use/end-user issues for a transaction), and the second sentence provides important when-not guidance: no restricted-party screening, cannot clear a transaction, and an empty result is not a compliance clearance. It does not explicitly name sibling tools as alternatives, so it stops just short of full 5-level routing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.